MECHANICSBURG, Pa., July 29, 2019 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has priced its private placement of $550.0 million aggregate principal amount of its 6.250% senior notes due 2026. The offering is expected to close on

DETROIT, July 29, 2019 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute, in partnership with

HOUSTON, July 29, 2019 /PRNewswire/ -- Today the national food safety law firm of Ron Simon & Associates filed a second lawsuit in the cyclospora outbreak linked to contaminated Mexican basil. 

SALT LAKE CITY, July 29, 2019 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced the closing of its initial public offering of 8,050,000 shares of its common stock at a price to the public of $26.00 per sha

BIRMINGHAM, Ala., July 29, 2019 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC), a national leader in integrated healthcare, offering facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies, today reported its results of operations for the second quarter ended June 30, 2019.

SECAUCUS, N.J., July 29, 2019 /PRNewswire/ -- Vitamin Shoppe, Inc. (NYSE: VSI), an omni-channel, specialty retailer of nutritional products, today announced that the Company will release its fiscal second quarter 2019 financial results before the market opens on Thursday, August 8, 2019.  A conference call will be webcast the same day b

OAKLAND, Calif., July 29, 2019 /PRNewswire/ -- Kaiser Permanente announced today that Prat Vemana has been named its first chief digital officer for Kaiser Foundation Health Plan and Hospitals. In this newly created role, Vemana will lead the ongoing development and execution of Kaiser Permanente's digital vision and strategy, in colla

SAN DIEGO, July 29, 2019 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2019 and provided an update on the launch of INGREZZA® (valbenazine) and its clinical development programs.

SILVER SPRING, Md., July 29, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease. The tests cleared today are the first time that a test has been indicated to follow a new testing paradigm in which two tests called enzyme immunoassays (EIA) are r

WASHINGTON D.C., July 29, 2019 /PRNewswire/ -- To help address the current emergency blood shortage, all who come to give blood or platelets with the American Red Cross July 29 through Aug. 29 will receive a $5 Amazon.com Gift Card via email. Currently, the Red Cross has less than a three-day supply of most